Open access

SAFETY AND EFFICACY OF SAR97276A FOR TREATING MALARIA: TWO OPEN-LABEL MULTICENTER PHASE II CLINICAL STUDIES IN AFRICAN CHILDREN AND ADULTS
Jana Held, Christian Supan, Carmen L. Ospina Salazar, Halidou Tinto, Léa Nadège Bonkian, Alain Nahum, Ali Sié, Salim Abdulla, Cathy Cantalloube, Elhadj Djeriou, Marielle Bouyou-Akotet, Bernhards Ogutu, Benjamin Mordmüller, Mohamadou Siribie, Sodiomon B. Sirima, Peter G. Kremsner

BMJ Global Health Feb 2017, 2 (Suppl 2) A23; DOI: 10.1136/bmjgh-2016-000260.58
TO VALUE THE EFFICIENCY OF PYRONARIDINE-ARTESUNATE AND ARTEMETHER-LUMEFANTRINE IN THE TREATMENT OF UNCOMPLICATED MALARIA OF PLASMODIUM SPP. IN BURKINA FASO
Nouhoun Barry, Naomie Kaboré, Zachari Kabré, Aminata Fofana, Fréderic Nikèma, Daniel Compaoré, Fabrice Somé, Issaka Zongo, Abdoulaye Djimdé, Jean Ouédraogo

BMJ Global Health Feb 2017, 2 (Suppl 2) A24-A25; DOI: 10.1136/bmjgh-2016-000260.62
ASSESSMENT OF SAFETY PARAMETERS FOLLOWING REPEATED ARTEMISIN-BASED TREATMENTS OF MALARIA-INFECTED PATIENT LIVING IN ENDEMIC AREA OF BURKINA FASO
Sam Coulibaly, Issiaka Soulama, Jean Moïse Kabore, San Maurice Ouattara, Edith Bougouma, Alphonse Ouedraogo, Souleymane Sanon, Diarra Amidou, Benjamin Sombie, Amidou Ouedraogo, Désiré Kargougou, Daouda Ouattara, Nebie Issa, Alfred Tiono, Sodiomon Sirima

BMJ Global Health Feb 2017, 2 (Suppl 2) A24; DOI: 10.1136/bmjgh-2016-000260.60
LUMEFANTRINE DISPOSITION AFTER REPETITIVE TREATMENT OF UNCOMPLICATED MALARIA PATIENTS WITH ARTEMETHER-LUMEFANTRINE IN MALI
Mamadou Tekete, Juergen Burhenne, Bakary Fofana, Sekou Toure, Souleymane Dama, Nianwalou Dara, Oumar Traore, Bouran Sidibe, Abdoulaye Djimde, Walter Haefeli, Steffen Borrmann

BMJ Global Health Feb 2017, 2 (Suppl 2) A24; DOI: 10.1136/bmjgh-2016-000260.61
ADVERSE EVENT (AE) REPORTING FROM MALARIA MASS DRUG ADMINISTRATION (MDA) ROUNDS CONDUCTED IN SOUTHERN ZAMBIA
Victor Chalwe, John Miller

BMJ Global Health Feb 2017, 2 (Suppl 2) A25; DOI: 10.1136/bmjgh-2016-000260.63
ONE MERCK FOR MALARIA PROGRAM: AN INTEGRATED R&D APPROACH TO FIGHT AGAINST MALARIA
Beatrice Greco, Thomas Spangenberg, Elly Kourany-Lefoll, Claude Oeuvray, Jim Mulry, Kamala Tyagarajan, Bettina Magsaam

BMJ Global Health Feb 2017, 2 (Suppl 2) A25-A26; DOI: 10.1136/bmjgh-2016-000260.65
TIME TO SECOND AND THIRD EPISODES OF MALARIA OF DIHYDROARTEMISININ−PIPERAQUINE VS ARTESUNATE−AMODIAQUINE AND ARTESUNATE−PYRONARIDINE VS ARTEMETER−LUMEFANTRINE IN BOUGOULA HAMEAU, MALI
Bakary Fofana, Abdoulaye Djimde, Hamadoun Diakité, Issaka Sagara, Ogobara Doumbo, Sekou Toure, Kassim Sanogo

BMJ Global Health Feb 2017, 2 (Suppl 2) A25; DOI: 10.1136/bmjgh-2016-000260.64
THE IMPACT PROJECT: IMPROVING THE IMPACT OF EXISTING MALARIA PRODUCTS – ACTS
Karen Barnes, Philippe Guérin, Eva Maria Hodel, Georgina Humphreys, Cheryl Pace, C.G Banda, Paulo Denti, Elizabeth Allen, David Lalloo, Victor Mwapasa, Anja Terlouw

BMJ Global Health Feb 2017, 2 (Suppl 2) A26; DOI: 10.1136/bmjgh-2016-000260.66
SPATIAL-TEMPORAL DYNAMICS IN HETEROGENEITY OF MALARIA INFECTION IN A SETTING WITH SEASONAL TRANSMISSION: A LONGITUDINAL STUDY IN THE GAMBIA
Julia Mwesigwa, Jane Achan, Musa Jawara, Gian Ditanna, Archibald Worwui, Muna Affara, Jean-Pierre Geertruyden, Umberto D'Alessandro

BMJ Global Health Feb 2017, 2 (Suppl 2) A26; DOI: 10.1136/bmjgh-2016-000260.67
GENETIC POLYMORPHISM OF MEROZOITE SURFACE PROTEIN-2 IN PLASMODIUM FALCIPARUM ISOLATES FROM DELIVERING WOMEN IN SOUTHERN BRAZZAVILLE, REPUBLIC OF CONGO
Félix Koukouikila-Koussounda, Michael Kombo, Christevy Vouvoungui, Francine Ntoumi

BMJ Global Health Feb 2017, 2 (Suppl 2) A26-A27; DOI: 10.1136/bmjgh-2016-000260.68

Main menu

Open access

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Open access

Pages